NCT00089635View on ClinicalTrials.gov

Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

203

Participants

Timeline

Start Date

August 1, 2004

Primary Completion Date

January 1, 2007

Study Completion Date

August 1, 2008

Conditions
Colorectal CancerMetastases
Interventions
DRUG

Panitumumab

Administered by intravenous infusion

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00089635 - Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter